Exclusive Access to Biotech's Top Decision-Makers
May 12-14, 2026 | ENCORE BOSTON HARBOR HOTEL, MA
Start building your 2026 package now.
Where biotech and pharma leaders discover the latest scientific breakthroughs and optimize R&D & clinical operations.
From May 12-14, 2026, Fierce Biotech Week brings together clinical operations, drug development, trial master file (TMF) and BD&L decision makers to share insights and collaborate around today's evolving healthcare landscape.
Our audience includes hundreds of biotech and pharma executives involved in drug development from early stages through FDA approval.
- C Level – CEO, CTO, CFO, Chief Business Officer, Chief Commercial Officer, Chief Medical Officer
- Executive VPs, VPs, Senior Director/Directors
- Managing Directors, Principals, Partners
- Heads of Clinical Documentation, Clinical Operations, Clinical Technology, Clinical Trial Management, GCP, Inspection Readiness, Risk Management, Trial Master File, Clinical Safety, Clinical Monitoring and more.
530+
Drug Development Leaders
Primary Market
Job Level
50% C-Level/EVP/SVP/VP
20% Director
8% Manager
22% Other
380+
BD&L
Executives
Primary Market
Job Level
76% C-Level/EVP/SVP/VP
16% Director
3% Manager
5% Other
350+
Clinical & TMF Professionals
Primary Market
Job Level
25% C-Level/EVP/SVP/VP
37% Director
20% Manager
18% Other
120+
PR &
Communications
Primary Market
Job Level
42% C-Level/EVP/SVP/VP
36% Director
10% Manager
12% Other
2026 Partner Opportunities & More
Be remembered before, during, and after the event.
Website Display

Newsletters

Video Interviews

Cross Channel Marketing
Ads


Social Media

In-person events are the most trusted information source
With misinformation on the rise, in-person events have emerged as the most trusted source of information. Face-to-face interactions foster not only credibility but also inspire fresh ideas, collaboration, and connection amidst ongoing global shifts.
Source: Winter 2024 Freeman Syndicated Survey of Event Attendees. Copyright Freeman 2024.
The power of presence
80%
In-Person Events
68%
Professional
Trade Orgs
61%
Academic
Institutions
44%
Webinars
42%
Company Leaders